Mirdametinib

( DrugBank: Mirdametinib / KEGG DRUG: Mirdametinib )


4 diseases

34. Neurofibromatosis


Clinical trials : 179 / Drugs : 259 - (DrugBank : 84) / Drug target genes : 90 - Drug target pathways : 211 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

278. Huge lymphatic malformation with cervicofacial lesion


Clinical trials : 47 / Drugs : 48 - (DrugBank : 15) / Drug target genes : 8 - Drug target pathways : 142 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

279. Huge venous malformation with cervical, oral and pharyngeal diffuse lesion


Clinical trials : 28 / Drugs : 36 - (DrugBank : 15) / Drug target genes : 6 - Drug target pathways : 138 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

280. Huge arteriovenous malformation with cervicofacial or limb lesion


Clinical trials : 36 / Drugs : 41 - (DrugBank : 17) / Drug target genes : 12 - Drug target pathways : 169 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries